SCHEMBL3169167

SCHEMBL3169167

C1CC[C@H]2COCC[C@@H]2C1

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14655 1.00 ALDH1A1 (0.47) ALDH1A1
SCHEMBL3169172 1.00 ALDH1A1 (0.47) ALDH1A1
SCHEMBL21339438 1.00 ALDH1A1 (0.47) ALDH1A1
SCHEMBL30522338 0.97 ALDH1A1 (0.44) ALDH1A1
SCHEMBL21841419 0.97 ALDH1A1 (0.44) ALDH1A1
SCHEMBL30223408 0.97 ALDH1A1 (0.44) ALDH1A1
SCHEMBL4245681 0.94
SCHEMBL18731783 0.89 ALDH1A1 (0.35) ALDH1A1
SCHEMBL10801830 0.88
SCHEMBL21829879 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956656-B2 Production of small particles NANO FIBER MATRICES B.V. (NL) 2015-02-17 US disclosed
US-7645805-B2 Gelling agents APPLIED NANOSYSTEMS, B.V. (NL) 2010-01-12 US disclosed
EP-1631261-B1 PRODUCTION OF SMALL PARTICLES APPLIED NANOSYSTEMS BV (NL) 2009-07-15 EP disclosed
US-7534915-B2 Non-symmetrical gelling agent APPLIED NANOSYSTEMS B.V. (NL) 2009-05-19 US disclosed
EP-1506168-B1 GELLING AGENTS APPLIED NANOSYSTEMS BV (NL) 2008-04-30 EP disclosed
US-20060276676-A1 Non-symmetrical gelling agent APPLIED NANOSYSTEMS B.V. (NL) 2006-12-07 US disclosed
EP-1682491-A1 NON-SYMMETRICAL GELLING AGENT Applied NanoSystems B.V. (NL) 2006-07-26 EP disclosed
US-20060099270-A1 Production of small particles APPLIED NANOSYSTEMS B.V. (NL) 2006-05-11 US disclosed
EP-1631261-A2 PRODUCTION OF SMALL PARTICLES Applied NanoSystems B.V. (NL) 2006-03-08 EP disclosed
US-20050250857-A1 Gelling agents NANO FIBER MATRICES B.V. (NL) 2005-11-10 US disclosed
WO-2005047231-A1 NON-SYMMETRICAL GELLING AGENT APPLIED NANOSYSTEMS B.V. (NL) 2005-05-26 WO disclosed
WO-2004103347-A2 PRODUCTION OF SMALL PARTICLES APPLIED NANOSYSTEMS B.V. (NL) 2004-12-02 WO disclosed
EP-1364941-A1 Gelling agents Applied NanoSystems B.V. (NL) 2003-11-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276676-A1 Non-symmetrical gelling agent PCNA, PGA5, GLA ALDH1A1 998/4885
US-20060099270-A1 Production of small particles NPC1L1, FDFT1, PGA5 ALDH1A1 3916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.